Treatment Related Risk Factors for Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

被引：0
|
作者：
No, H. J. [1 ]
Tam, M. M. [2 ]
Wu, P. [3 ]
机构：
[1] Flushing Hosp Med Ctr, Flushing, NY USA
[2] NYU Langone Hlth, Dept Radiat Oncol, New York, NY USA
[3] Holy Name Med Ctr, Teaneck, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页码：1214 / 1214
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy
    Sheth, S.
    Bauman, J. R.
    Deal, A.
    Chera, B.
    Shen, C.
    Galloway, T.
    Hackman, T.
    Blumberg, J.
    Yarbrough, W.
    Weissler, M.
    Hilliard, C.
    Mehra, R.
    Grilley-Olson, J.
    Weiss, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Response of chemoradiation therapy after induction chemotherapy failure in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
    Lim, Yoojoo
    Keam, Bhumsuk
    Koh, Youngil
    Lee, Kyung-Hun
    Kim, Tae Min
    Lee, Se-Hoon
    Hah, Jeong-Hun
    Kwon, Tack-Kyun
    Kim, Dong-Wan
    Wu, Hong-Gyun
    Sung, Myung-Whun
    Heo, Dae Seog
    Kim, Kwang Hyun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Factors associated with hospitalization in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with definitive chemoradiation (CRT).
    Park, Soo J.
    Parikh, Mili
    Harrington, Joanne
    Heppner, Pia
    McCarthy, Kelly
    Crandall, Bailey
    Wong-Sefidan, Ida
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
    Garcia, Enrique Sanz
    Zou, Jinfeng
    Avery, Lisa
    Spreafico, Anna
    Waldron, John
    Goldstein, David Paul
    Hansen, Aaron Richard
    Cho, John
    de Almeida, John R.
    Hope, Andrew
    Hosni, Ali
    Hahn, Ezra
    Perez-Ordonez, Bayardo
    Zhao, Zhen
    Smith, Christopher Gareth
    Zheng, Yangqiao
    Rosenfeld, Nitzan
    Singaravelan, Nittusha
    Bratman, Scott Victor
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results from an EORTC led survey
    Oosting, S.
    Desideri, I.
    Staelens, D.
    Caballero, C.
    Tribius, S.
    Simon, C.
    Singer, S.
    Gregoire, V.
    Fortpied, C.
    Luciani, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 393 - 393
  • [6] Impact of comprehensive geriatric assesment (CGA) in the treatment decision and outcome of older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
    Llop Serna, Sandra
    Ejarque Martinez, Clara
    Brenes Castro, Jesus
    Honorato, Macarena
    Vilajosana Altamis, M. Esther
    Melero, Mireia
    Bermejo, Oriol
    Gomez Garcia, Victoria
    Fulla, Marta
    Goma, Montse
    Linares, Isabel
    Lozano, Alicia
    Taberna, Miren
    Mesia, Ricard
    Plana, Maria
    Antonio Rebollo, Maite
    Oliva Bernal, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Impact of COVID19 pandemic on treatment outcome of locally-advanced head and neck squamous cell carcinoma (LA-HNSCC): IMPACCT study.
    Guillen Sentis, Pau
    Castillo Manzano, Carmen
    Quiros, Beatriz
    Morey Cortes, Francisca
    Tous, Sara
    Plana, Maria
    Brenes Castro, Jesus
    Lozano, Alicia
    Linares, Isabel
    Vilajosana Altamis, M. Esther
    Gomez Garcia, Victoria
    Labori Trias, Maria
    Goma, Montse
    Mari Roig, Antonio
    Bermejo, Oriol
    Tornero Salto, Jordi
    Taberna, Miren
    Alemany, Laia
    Mesia, Ricard
    Oliva Bernal, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Pembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial
    Machiels, J-P.
    Licitra, L.
    Rischin, D.
    Waldron, J.
    Burtness, B.
    Gregoire, V.
    Shekar, T.
    Brown, H. M.
    Cheng, J.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
    Machiels, Jean -Pascal H.
    Licitra, Lisa
    Rischin, Danny
    Waldron, John
    Burtness, Barbara
    Gregoire, Vincent
    Shekar, Tulin
    Brown, Holly M.
    Cheng, Jonathan D.
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Gastrostomy Tube (GT) Outcomes in Primary Chemoradiation for Squamous Cell Carcinoma of Head and Neck (HNSCC)
    Ho, J. W.
    Donaldson, M.
    Christian, J. A.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S33 - S33
12345